Chapter 5 Market Dynamics
- Market Drivers
- Increasing Incidences of Chronic Diseases
- Growing Aging Population
- Advancements in Manufacturing Technologies
- Market Restraints
- Price Controls
- Entry of Biosimilars
- Opportunities
- Untapped Potential in Emerging Markets
Chapter 6 Market Breakdown by Product Type
- Human Protein Replacements
- Market Size and Forecast
- Therapeutic Agents for Human Diseases
- Market Size and Forecast
- Vaccines
- Types of Vaccines
- Market Size and Forecast
Chapter 7 Market Breakdown by End-user
- Biotechnology and Pharmaceutical Industry
- Market Size and Forecast
- Research Laboratories and Academic Institutes
- Market Size and Forecast
Chapter 8 Market Breakdown by Region
- Global Market by Region
- North America
- Europe
- Asia-Pacific
- Rest of the World
Chapter 9 Competitive Landscape
Chapter 10 Company Profiles
- Abbvie Inc.
- Alexion Pharmaceuticals
- Amgen Inc.
- Eli Lilly
- Merck & Co. Inc.
- Sanofi S.A.
- Takeda Pharmaceutical Co Ltd.
List of Tables
Summary Table: Global Market for Human Recombinant DNA, by Region, Through 2027
Table 1: Estimated World Population and Annual Growth, by Selected Age Group, Through 2030
Table 2: Cancer Statistics Across Major Asian Countries, by Cancer Site/Type, 2020
Table 3: Global Human Recombinant DNA Market, by Product Type, Through 2027
Table 4: Global Market for Human Protein Replacements, by Region, Through 2027
Table 5: Global Market for Therapeutic Agents for Human Diseases, by Region, Through 2027
Table 6: Vaccine Types
Table 7: Global Market for Vaccines, by Region, Through 2027
Table 8: Global Market for Human Recombinant DNA, by End User, Through 2027
Table 9: Global Market for Human Recombinant DNA in the Biotechnology and Pharmaceutical Industry, by Region, Through 2027
Table 10: Global Market for Human Recombinant DNA in Research Laboratories and Academic Institutes, by Region, Through 2027
Table 11: Global Market for Human Recombinant DNA, by Region, Through 2027
Table 12: North American Market for Human Recombinant DNA, by Product Type Through 2027
Table 13: North American Market for Human Recombinant DNA, by End User, Through 2027
Table 14: North American Market for Human Recombinant DNA, by Country, Through 2027
Table 15: European Market for Human Recombinant DNA, by Product Type, Through 2027
Table 16: European Human Recombinant DNA Market, by End User, Through 2027
Table 17: European Market for Human Recombinant DNA, by Country, Through 2027
Table 18: Asia-Pacific Market for Human Recombinant DNA, by Product Type, Through 2027
Table 19: Asia-Pacific Human Recombinant DNA Market, by End User, Through 2027
Table 20: Asia-Pacific Market for Human Recombinant DNA, by Country, Through 2027
Table 21: Japan: Total Number of New Cancer Cases in Both Genders, 2020
Table 22: RoW Market for Human Recombinant DNA, by Product Type, Through 2027
Table 23: RoW Market for Human Recombinant DNA, by End User, Through 2027
Table 24: Leading Market Players in the Human Recombinant DNA Market Ecosystem
Table 25: AbbVie Inc.: Business Segments
Table 26: AbbVie Inc.: Financial Performance, Through 2020
Table 27: Amgen: Financial Performance, Through 2020
Table 28: Eli Lilly: Business Segments
Table 29: Eli Lilly: Financial Performance, 2018-2020
Table 30: Sanofi: Business Segments
Table 31: Sanofi: Financial Performance, 2018-2020
List of Figures
Summary Figure A: Global Market for Human Recombinant DNA, by Region, 2020-2027
Summary Figure B: Global Market Shares of Human Recombinant DNA, by Region, 2021
Figure 1: Global Market Shares of Human Recombinant DNA, by Product Type, 2021
Figure 2: Global Market for Human Recombinant DNA, by Product Type, 2020-2027
Figure 3: Global Market for Human Protein Replacements, 2020-2027
Figure 4: Global Market for Therapeutic Agents for Human Diseases, 2020-2027
Figure 5: Evolution of Vaccine Technologies
Figure 6: Global Market for Vaccines, 2020-2027
Figure 7: Global Market Shares of Human Recombinant DNA, by End User, 2021
Figure 8: Global Market for Human Recombinant DNA, by End User, 2020-2027
Figure 9: Global Market for Human Recombinant DNA in the Biotechnology and Pharmaceutical Industry, 2020-2027
Figure 10: Global Market for Human Recombinant DNA in Research Laboratories and Academic Institutes, 2020-2027
Figure 11: Global Market Shares of Human Recombinant DNA, by Region, 2021
Figure 12: North American Market Shares of Human Recombinant DNA, by Product Type, 2021
Figure 13: North American Market Shares of Human Recombinant DNA, by End User, 2021
Figure 14: North American Market Shares of Human Recombinant DNA, by Country, 2021
Figure 15: U.S. Market for Human Recombinant DNA, 2020-2027
Figure 16: Canadian Market for Human Recombinant DNA, 2020-2027
Figure 17: European Market Shares of Human Recombinant DNA, by Product Type, 2021
Figure 18: European Human Recombinant DNA Market, Market Shares, by End User, 2021
Figure 19: European Market Shares of Human Recombinant DNA, by Country, 2021
Figure 20: Geriatric Population in Germany, 2000-2030
Figure 21: German Market for Human Recombinant DNA, 2020-2027
Figure 22: U.K. Market for Human Recombinant DNA, 2020-2027
Figure 23: French Market for Human Recombinant DNA, 2020-2027
Figure 24: Italian Market for Human Recombinant DNA, 2020-2027
Figure 25: Spanish Market for Human Recombinant DNA, 2020-2027
Figure 26: Rest of Europe Market for Human Recombinant DNA, 2020-2027
Figure 27: Asia-Pacific Market Shares of Human Recombinant DNA, by Product Type, 2021
Figure 28: Asia-Pacific Human Recombinant DNA Market, Market Shares, by End User, 2021
Figure 29: Asia-Pacific Market Shares of Human Recombinant DNA, by Country, 2021
Figure 30: New Cancer Cases in China, 2020
Figure 31: Distribution of New Cancer Cases in China, 2020
Figure 32: Chinese Market for Human Recombinant DNA, 2020-2027
Figure 33: Japanese Market for Human Recombinant DNA, 2020-2027
Figure 34: Indian Market for Human Recombinant DNA, 2020-2027
Figure 35: Rest of Asia-Pacific Market for Human Recombinant DNA, 2020-2027
Figure 36: New Cancer Cases in Africa, 2020
Figure 37: RoW Market Shares of Human Recombinant DNA, by Product Type, 2021
Figure 38: RoW Market Shares of Human Recombinant DNA, by End User, 2021
Figure 39: AbbVie Inc.: Net Revenue, by Business Segment, 2020
Figure 40: AbbVie Inc.: Net Revenue, by Region, 2020
Figure 41: Amgen: Total Sales, by Product, 2020
Figure 42: Amgen: Total Revenue, by Region, 2020
Figure 43: Eli Lilly: Total Sales, by Product Segment, 2020
Figure 44: Eli Lilly: Total Revenue, by Region, 2020
Figure 45: Sanofi: Net Sales, by Business Segment, 2020
Figure 46: Sanofi: Net Sales, by Region, 2020
